home / stock / bhvn / bhvn articles

BHVN Articles, Biohaven Pharmaceutical Holding Company Ltd.

Stock Information
Company Name: Biohaven Pharmaceutical Holding Company Ltd.
Stock Symbol: BHVN
Market: NYSE
Menu
BHVN BHVN Quote BHVN Short BHVN News BHVN Articles BHVN Message Board
Get BHVN Alerts

News, Short Squeeze, Breakout and More Instantly...
HP Posts Upbeat Earnings, Joins Foot Locker, American Superconductor, Red Robin Gourmet Burgers And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks were lower, with the Dow Jones index falling around 1% on Thursday. Shares of HP Inc. (NYSE:HPQ) rose sharply during Thursday's se...
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study | Benzinga

Biohaven Ltd’s (NYSE:BHVN) shares are trading lower on Wednesday. The company reported new interim data from the ongoing Phase 1 study of BHV...

What's Going On With Biohaven Stock Wednesday? | Benzinga

Biohaven Ltd. (NYSE:BHVN) stock is moving lower Wednesday. The company recently presented several updates in different fields such as immunology an...

This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan | Benzinga

The Structure Therapeutics (NASDAQ:GPCR) stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a...
Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Around $1M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying | Benzinga

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidenc...

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the P...
Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday? | Benzinga

Wednesday, Altimmune Inc (NASDAQ:ALT) said the body composition study of pemvidutide showed lean mass preservation, with 25.5% of weight ...

Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly | Benzinga

Monday, Biohaven’s (NYSE:BHVN) CEO, Vlad Coric, joined CNBC Fast Money to discuss the weight loss drug wars and the company...

This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space | Benzinga

RBC Capital Markets has initiated Biohaven Ltd (NYSE:BHVN), noting optimized development across programs. The analyst highlight...
Next 10